Editorials

HOXA9/MEIS1 targets in leukemia: reinforced signaling networks and therapeutic opportunities

Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA; O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294
Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA; O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294
Haematologica Early view Aug 25, 2022 https://doi.org/10.3324/haematol.2022.281779